Posted inBusiness News Entrepreneurship Investments
Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly
Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn't meet its primary target. The drug, CagriSema, didn't achieve its primary endpoint of demonstrating…






